Cogentix Medical Reports 83% Second Quarter Revenue Growth
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P dip, trading choppy as tech stocks fall
- Brent hits lowest since before start of Iran war as more tankers exit Hormuz, easing supply
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Roth Capital Upgrades Cogentix Medical (CGNT) to Buy
November 5, 2015 7:24 AM ESTRoth Capital upgraded Cogentix Medical (NASDAQ: CGNT) from Neutral to Buy with a price target of $3.00 (from $1.85).
Analyst Chris Lewis commented, "Given our confidence for CGNT to sustain double-digit revenue growth with opportunities for acceleration as EndoSheath sales productivity materializes, paired with notable... More
Cogentix Medical (CGNT) Misses Q2 EPS by 2c
November 3, 2015 4:51 PM ESTCogentix Medical (NASDAQ: CGNT) reported Q2 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $11.8 million versus the consensus estimate of $11.45 million.
Cogentix Medical sees FY2015 revenue of $49-51 million, versus the consensus of $50.0 million.
For earnings... More
